<DOC>
	<DOC>NCT01659567</DOC>
	<brief_summary>This prospective observational study will investigate predictive values of virological response in peginterferon/ribavirin treatment-naive patients with chronic hepatitis C. Patients will be treated with Pegasys (peg-interferon alpha 2a) and Copegus (ribavirin) as prescribed by the physician. Data will be collected for 72 weeks.</brief_summary>
	<brief_title>An Observational Study of Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<criteria>Adult patients, &gt;/=18 years of age Diagnosis of chronic hepatitis C infection Coinfection with human immunodeficiency virus (HIV) and/or hepatitis B Patients previously treated with peginterferon/ribavirin Participation in another clinical study within 30 prior to study start of ML25544</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>